Hydrotalcite market segment – CRI Report https://www.cri-report.com market research vender! Thu, 02 Dec 2021 07:18:52 +0000 en-US hourly 1 https://www.cri-report.com/wp-content/uploads/2021/01/cropped-shcrilogo-c.jpg Hydrotalcite market segment – CRI Report https://www.cri-report.com 32 32 Investigation Report on China’s Hydrotalcite Market, 2021-2025 https://www.cri-report.com/investigation-report-on-chinas-hydrotalcite-market-2021-2025/ Tue, 08 Jun 2021 05:57:01 +0000 https://www.cri-report.com/?post_type=product&p=11768 The sales value of Hydrotalcite in the Chinese market decreased by 49.28% year on year because of the outbreak of the COVID-19 epidemic in 2020 and the effects of government procurement.

The post Investigation Report on China’s Hydrotalcite Market, 2021-2025 first appeared on CRI Report.

]]> Hydrotalcite is suitable for acute and chronic gastritis, reflux esophagitis, gastric and duodenal ulcers, stomach pain, heartburn, acid belching, fullness and other uncomfortable symptoms related to gastric acid. It is also used to prevent gastric mucosal damage caused by non-steroidal drugs. Hydrotalcite, developed by Bayer Pharmaceuticals in Germany was approved in China in 1996. As of 2020, in addition to the original research company, the main manufacturers in the Chinese Hydrotalcite market are Chongqing Pharscin Pharmaceutical Co., Ltd., Guangdong Huarun Shunfeng Pharmaceutical Co., Ltd., Ltd., Sichuan Jianneng Pharmaceutical Co., Ltd. and Hubei Ouly Pharmaceutical Co., Ltd.

According to CRI’s research market, the sales of Hydrotalcite in the Chinese market were generally stable from 2016 to 2019. The sales value of Hydrotalcite in the Chinese market decreased by 49.28% year on year because of the outbreak of the COVID-19 epidemic in 2020 and the effects of government procurement. The CAGR of China’s Hydrotalcite sales value from 2016 to 2020 is -15.36%.

CRI predicts that the sales of Hydrotalcite in China will have a restorative growth from 2021 to 2025 as the alleviation of the COVID-19 epidemic. In addition, in the context of an aging population and unhealthy lifestyles, the number of patients with gastrointestinal diseases in China will continue to increase, and the sales value and sales volume of Hydrotalcite used to treat acute and chronic gastroenteritis and other gastrointestinal diseases will increase. It is estimated that China’s Hydrotalcite sales market by sales value will exceed CNY100 million.

Topics Covered:
-Development environment of Chinese Hydrotalcite market
-Governmental approval of Hydrotalcite in China
-Prices of Hydrotalcite in China
-Major Hydrotalcite manufacturers in China
-Factors influencing the development of Chinese Hydrotalcite market
-Prospects of Chinese Hydrotalcite market

The post Investigation Report on China’s Hydrotalcite Market, 2021-2025 first appeared on CRI Report.

]]> Investigation Report on China’s Hydrotalcite Market, 2018-2022 https://www.cri-report.com/investigation-report-on-chinas-hydrotalcite-market-2018-2022/ Wed, 02 Jan 2019 02:40:10 +0000 https://www.cri-report.com/product/import-placeholder-for-1901370/ By the end of 2018, more than 20 manufacturers have obtained the approval for Hydrotalcite production. However, China's Hydrotalcite market is highly concentrated.

The post Investigation Report on China’s Hydrotalcite Market, 2018-2022 first appeared on CRI Report.

]]> Description
The incidences of gastrointestinal diseases are rising in China with the development of China’s economy, the change of dietary habits and daily routines, and the intensification of environmental pollution. It is estimated that the number of patients with gastrointestinal diseases in China has exceeded 120 million, and is still growing, with the incidence of chronic gastritis hovering at 30%.
According to CRI’s market research, the top 5 chemical drugs for gastritis and peptic ulcer in China are all proton-pump inhibitors. Among them, the gastric mucosal protective agents represented by Hydrotalcite are featured by high safety, few side effects, and quick relief, and thus saw a growing market demand. Hydrotalcite is a gastric mucosal protective agent that can quickly neutralize gastric acid, reduce the stimulation and corrosion of gastric acid on the esophageal mucosa, and significantly relieve pains. It can also accelerate the healing of ulcers. Used to treat acute and chronic gastritis, reflux esophagitis, peptic ulcer, heartburn and stomach upset related to gastric acid, it can relieve the cardialgia, acid reflux, nausea, vomiting, abdominal distension and other symptoms caused by excessive gastric acid, and prevent the gastric mucosal lesions caused by nonsteroidal anti-inflammatory drugs.
In 2017, the market size of Hydrotalcite in China was close to CNY 110 million. The Hydrotalcite products in China are marketed in the dosage forms of suspension, tablets and granules. The market is dominated by the tablets.
By the end of 2018, more than 20 manufacturers have obtained the approval for Hydrotalcite production. However, China’s Hydrotalcite market is highly concentrated. In 2017, by sales value, more than 90% market share went to the top 5 market players, namely, Bayer, Chongqing Pharscin Pharmaceutical Co., Ltd., Sichuan Jewelland Pharmaceutical Co., Ltd., Hainan Health Care Laboratories Ltd., and Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. And Bayer alone took up a market share of over 80%.
With the quickening pace of life, the change of dietary habits and the intensification of environmental pollution, the number of patients with gastrointestinal diseases in China will continue to rise in the coming years, which promises certain growth potential for China’s Hydrotalcite market.

Topics Covered:
– Situation of gastrointestinal diseases in China
– Status of China’s Hydrotalcite market
– Competition on China’s Hydrotalcite market
– Prices of Hydrotalcite in China
– Major factors influencing the development of China’s Hydrotalcite market
– Prospect of China’s Hydrotalcite market, 2018-2022

https://www.cri-report.com/product/investigation-report-on-chinas-hydrotalcite-market-2021-2025/

 

The post Investigation Report on China’s Hydrotalcite Market, 2018-2022 first appeared on CRI Report.

]]>